How to Build a Compounding Formulation Database and Formula Library
A practical, rights-aware guide for Canadian compounding pharmacies to build an original formulation database using authorized sources while organizing master formulations, supporting references, BUD rationale, version control, and related compounding documentation.
Reviewed August 11, 2026 · Educational resource
01
Use sources you are permitted to use
✓Primary peer-reviewed formulation and stability studies obtained lawfully
✓Official standards, regulator guidance and public government information
✓Pharmacopoeial monographs, specialist formularies and databases covered by a valid licence
✓Manufacturer and supplier technical data, specifications, CoAs and SDS documents
✓Original pharmacy experience or testing that is documented, reviewed and ethically usable
02
Do not copy a competitor's product
✓Do not reproduce RxVigilance or another provider's formula records, procedures, descriptions, screenshots, selection or database structure without permission
✓Do not paraphrase line by line to disguise copying; write independently from verified facts and multiple authorized sources
✓If a licence permits consultation but not redistribution, cite the source internally and do not republish its protected content
✓Keep a source-and-rights register showing access method, licence terms, permitted use and reviewer
03
Create each record independently
✓Define the intended preparation, exact ingredient forms, grade, strength, dosage form and batch size
✓Verify calculations, solubility, compatibility, process, packaging, storage and quality controls
✓Write an original MFR in language matched to the pharmacy's actual equipment and workflow
✓Create a formula-specific risk assessment and a separate BUD evidence assessment
✓Record every source precisely and distinguish published evidence from professional inference
04
Release through governance
✓Independent calculation and technical review
✓Pharmacy authorization before any formula is used
✓Version control, review date, change control and withdrawal process
✓Clear status labels such as draft, under review, approved or retired
✓Legal review of licensing and copyright terms before commercial distribution